Decrease of intrathyroidal CD161+Vα24+Vβ 11+ NKT cells in Graves' disease

Endocrine Journal

Volumn 55, Issue 1, 2008, Pages 199-203

  Watanabe, Mikio ^a   Nakamura, Yukiyo ^a   Matsuzuka, Fumio ^b   Takamura, Yuuki ^b   Miyauchi, Akira ^b   Iwatani, Yoshinori ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KUMA HOSPITAL   (Japan)

Author keywords

Autoimmunity; Graves' disease; Immunoregulation; NKT cell; Thyroid

Indexed keywords

CD161 ANTIGEN; T LYMPHOCYTE RECEPTOR; KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY B; KILLER CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; LECTIN; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOIMMUNITY; BLOOD; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GRAVES DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; MALE; NATURAL KILLER T CELL; PERIPHERAL LYMPHOCYTE; THYROID GLAND; VOLUNTEER; ADOLESCENT; CASE CONTROL STUDY; DOWN REGULATION; IMMUNOLOGY; LYMPHOCYTE COUNT; METABOLISM; MIDDLE AGED; NATURAL KILLER CELL; PATHOLOGY;

ADOLESCENT; ADULT; ANTIGENS, SURFACE; CASE-CONTROL STUDIES; DOWN-REGULATION; FEMALE; GRAVES DISEASE; HUMANS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; THYROID GLAND;

EID: 42049092367     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K07E-006     Document Type: Article

References (22)

1. Volpe R (2001) The immune system and its role in endocrine function. In: Becker KL (eds) Principles and practice of endocrinology and metabolism. Lippincott Williams & Wilkins, Philadelphia: 1770-1781.
2. Weetman AP (2001) Determinants of autoimmune thyroid disease. Nat Immunol 2: 769-770.
3. Weetman AP (2003) Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol 148: 1-9.
4. Davies TF (2000) Pathogenesis of Graves' disease. In: Braverman LE and Utiger RD (eds) The thyroid - a fundamental and clinical text. Lippincott Williams & Wilkins, Philadelphia: 518-531.
5. + B cells in hyperthyroid Graves' disease. Clin Exp Immunol 78: 196-200.
6. + cells in active Hashimoto's disease and subacute thyroiditis. Clin Exp Immunol 87: 444-449.
7. - cells, in autoimmune thyroid disease. Clin Exp Immunol 93: 430-436.
8. Maruoka H, Watanabe M, Matsuzuka F, Takimoto T, Miyauchi A, Iwatani Y (2004) Increased intensities of fas expression on peripheral T-cell subsets in severe autoimmune thyroid disease. Thyroid 14: 417-423.
9. + macrophages/dendritic cells express Fas ligand in autoimmune thyroid disease. Thyroid 14: 819-824.
10. + regulatory T cells in autoimmune thyroid diseases. Thyroid 17: 25-31.
11. Ito C, Watanabe M, Okuda N, Watanabe C, Iwatani Y (2006) Association between the severity of Hashimoto's disease and the functional +874A/T polymorphism in the interferon-gamma gene. Endocr J 53: 473-478.
12. Linsen L, Somers V, Stinissen P (2005) Immunoregulation of autoimmunity by natural killer T cells. Hum Immunol 66: 1193-1202.
13. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L (2004) NKT cells: what's in a name? Nat Rev Immunol 4: 231-237.
14. Seino K, Taniguchi M (2004) Functional roles of NKT cell in the immune system. Front Biosci 9: 2577-2587.
15. Godfrey DI, Kronenberg M (2004) Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest 114: 1379-1388.
16. +CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J Exp Med 187: 1047-1056.
17. + T-cell repertoire leads to circulating NKT-cell defects in a multiple sclerosis patient at the onset of his disease. Immunol Lett 90: 223-228.
18. Illes Z, Kondo T, Newcombe J, Oka N, Tabira T, Yamamura T (2000) Differential expression of NK T cell Va24 JaQ invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J Immunol 164: 4375-4381.
19. + NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin Immunol 100: 144-148.
20. Kitamura H, Iwakabe K, Yahata T, Nishimura S, Ohta A, Ohmi Y, Sato M, Takeda K, Okumura K, Van Kaer L, Kawano T, Taniguchi M, Nishimura T (1999) The natural killer T (NKT) cell ligand a-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J Exp Med 189: 1121-1128.
21. Watanabe M, Yamamoto N, Matsuzuka F, Miyauchi A, Iwatani Y (2004) Decrease of CD154 intensity on peripheral CD4+ T cells in autoimmune thyroid disease. Clin Exp Immunol 136: 555-558.
22. Kumanogoh A, Wang X, Lee I, Watanabe C, Kamanaka M, Shi W, Yoshida K, Sato T, Habu S, Itoh M, Sakaguchi N, Sakaguchi S, Kikutani H (2001) Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: a role of CD40 in regulatory T cell development. J Immunol 166: 353-360.